Tabla de Contenidos:
  • Cover
  • Table of Contents
  • 1 Introduction
  • 2 Defects in Host Defense Mechanisms
  • 1. Colonization
  • 2. First Line of Defense
  • 3. Second Line of Defense
  • 4. Factors that Influence the Quality of Host Defense
  • 5. Diseases that Affect Host Defense
  • 6. Immunosuppressive Drugs
  • 7. Plasmapheresis
  • 8. Radiation
  • 9. Attempts to Strengthen Host Defense
  • References
  • 3 Mucocutaneous Infections in the Immunocompromised Host
  • 1. Introduction
  • 2. Skin as a Barrier to Infection
  • 3. Types of Skin Infection
  • 4. Diagnostic Aspects of Skin Infections in the Compromised Patient
  • 5. Opportunistic Infections by Pathogen
  • 6. Diagnostic Aspects of Skin Infections in the Compromised Patient
  • 7. Inflammatory Disorders that Simulate Infection in the Compromised Host
  • 8. Conclusion
  • Bibliography
  • References
  • 4 with Fever and Pulmonary Infiltrates Clinical Approach to the Compromised Host
  • 1. The Febrile Pneumonitis Syndrome and Its Importance
  • 2. Overview of the Infectious Causes of the Febrile Pneumonitis Syndrome in the Immunocompromised Host
  • 3. Overview of Noninfectious Causes of the Febrile Pneumonitis Syndrome
  • 4. Radiologic Clues to the Diagnosis of the Febrile Pneumonitis Syndrome
  • 5. Specific Diagnosis
  • 6. Superinfection
  • References
  • 5 Central Nervous System Infection in the Immunocompromised Host
  • 1. Introduction
  • 2. Viral Infections
  • 3. Bacterial Infections
  • 4. Fungal Infections
  • 5. Protozoal Infections
  • References
  • 6 Fungal Infections in the Immunocompromised Host
  • 1. Introduction
  • 2. Antifungal Prophylaxis in the Immunocompromised Host
  • 3. Empiric Antifungal Therapy in Neutropenic Patients with Persistent Fever
  • 4. Candidiasis
  • 5. Aspergillosis
  • 6. Zygomycosis
  • 7. Fusariosis
  • 8. Cryptococcosis
  • 9. Histoplasmosis
  • 10. Coccidioidomycosis
  • 11. Blastomycosis
  • 12. Unusual Fungal Pathogens
  • 13. Antifungal Agents
  • References
  • 7 Mycobacterial and Nocardial Diseases in the Compromised Host
  • 1. Introduction
  • 2. Microbiologic Classification and Clinical Syndromes
  • 3. Pathogenesis and Epidemiology
  • 4. Treatment of Tuberculosis, Drug-Resistant Tuberculosis, and Alternative Antituberculosis Chemotherapy
  • 5. Nocardiosis
  • References
  • 8 Pneumocystis carinii and Parasitic Infections in the Immunocompromised Host
  • 1. Introduction
  • 2. Pneumocystis carinii
  • 3. Toxoplasma gondii
  • 4. Cryptosporidium Species
  • 5. Isospora belli
  • 6. Microsporidia
  • 7. Strongyloides stercoralis
  • 8. Entamoeba histolytica and Amebiasis
  • 9. Primary Amebic Meningoencephalitis
  • 10. Leishmaniasis
  • 11. Other Parasitic Diseases of the Immunocompromised Host
  • References
  • 9 Viral Hepatitis in the Compromised Host
  • 1. Introduction
  • 2. Role of Immunologic Mechanisms in the Pathogenesis of Viral Hepatitis
  • 3. Viral Hepatitis in the Immunocompromised Host
  • 4. Prevention
  • 5. Summary
  • References
  • 10 The Herpesviruses
  • 1. General Characteristics of Herpesviruses
  • 2. Characteristics of Particular Herpesviruses
  • tidtid2001.